Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

The Journal of pathology - 1 Apr 2003

Moreno-Bueno Gema, Hardisson David, Sarrió David, Sánchez Carolina, Cassia Raúl, Prat Jaime, Herman James G, Esteller Manel, Matías-Guiu Xavier, Palacios José

Abstract excerpt

Abnormal expression of cadherins and catenins plays a critical role in the initiation and progression of multiple human tumours. This study aimed to evaluate the immunoreactivity of E- and P-cadherin, beta- and gamma-catenin, and p120ctn in premalignant and malignant endometrial lesions and to correlate their membranous expression with clinicopathological features. In addition, we examined whether or not LOH and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Catenins

Share to Cell Adhesion Molecules

Share to Delta Catenin

Share to Endometrial Hyperplasia

Share to Endometrial Neoplasms

Share to Precancerous Conditions

Source

Identifiers

PMID: 12635138
DOI: 10.1002/path.1310

Genes

CDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.PMID 12635138Read ↗

Abnormalities of the APC/beta-catenin pathway in endometrial cancer.Semantic proximity Read ↗

Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).Semantic proximity Read ↗

Molecular pathology of endometrial hyperplasia and carcinoma.Semantic proximity Read ↗

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.Semantic proximity Read ↗

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.Semantic proximity Read ↗

Aberrant Methylation of the E-Cadherin Gene Promoter Region in Endometrium and Ovarian Endometriotic Cysts of Patients with Ovarian EndometriosisSemantic proximity Read ↗

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.Semantic proximity Read ↗

Cadherin and catenin alterations in human cancer.Semantic proximity Read ↗

Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.Semantic proximity Read ↗

Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization.Semantic proximity Read ↗

Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.Semantic proximity Read ↗

Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.